SPACA9
Sperm acrosome-associated protein 9
Also known as: C9orf9, Mast, SACA9_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96E40
- Gene
- SPACA9
- Ensembl
- ENSG00000165698
- Chromosome
- 9
- Canonical length
- 222 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol,End piece
OverviewNCBI Gene
Enables microtubule binding activity. Involved in axoneme assembly. Located in axonemal microtubule. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
222 residues, UniProt reviewed canonical sequence.
>Q96E40|SPACA9
1 MNEVKESLRS IEQKYKLFQQ QQLTFTAALE HCRENAHDKI RPISSIGQVQ SYMEHYCNSS
61 TDRRVLLMFL DICSELNKLC QHFEAVHSGT PVTNNLLEKC KTLVSQSNDL SSLRAKYPHD
121 VVNHLSCDEA RNHYGGVVSL IPLILDLMKE WIAHSEKLPR KVLQHVSEPQ AHQESTRGAA
181 RPAQAIGTQP RATKHKCRQL TKASLKPRGC SKPPWRPPGG KLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPACA9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 125 nTPM
Expression across tissuesHPA
Tissue
- testis: 125 nTPM
- epididymis: 70 nTPM
- fallopian tube: 37 nTPM
- choroid plexus: 18 nTPM
- hypothalamus: 18 nTPM
- basal ganglia: 17 nTPM
Single-cell type
- late spermatids: 2,904 nCPM
- early spermatids: 2,419 nCPM
- late primary spermatocytes: 637 nCPM
- epididymal principal cells: 258 nCPM
- respiratory ciliated cells: 227 nCPM
- fallopian tube ciliated cells: 130 nCPM
Immune cell
- NK-cell: 4.4 nTPM
- basophil: 4 nTPM
- memory B-cell: 3 nTPM
- naive B-cell: 2.6 nTPM
- T-reg: 2 nTPM
- eosinophil: 1.9 nTPM
Brain region
- midbrain: 29 nTPM
- spinal cord: 27 nTPM
- medulla oblongata: 25 nTPM
- hypothalamus: 22 nTPM
- white matter: 21 nTPM
- choroid plexus: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.62
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sperm acrosome-associated protein 9
- Sperm acrosome-associated protein 9
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPACA9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPACA9 as an antibody target. Whether an autoantibody or antibody against SPACA9 could matter depends on whether native SPACA9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPACA9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPACA9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...